Dr. Nam S. Cho, DO

Dr. Cho practices at UM Health-Sparrow Lansing Campus in Lansing, Michigan.

Dr. Cho's NPI, 1255339263, was assigned on July 13, 2005. Dr. Cho holds Michigan license 4301052699.

Dr. Cho's primary practice is UM Health-Sparrow Lansing Campus, at 1215 E Michigan Ave, Lansing, MI 48912 in Ingham County. The practice phone is (517) 364-6000.

Dr. Cho's primary practice is UM Health-Sparrow Lansing Campus in Lansing, Michigan. Dr. Cho is also affiliated with University of Michigan Health-Sparrow Lansing. The medical group on file is University of Michigan Health-Sparrow. Dmand AI also links Dr. Cho to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Cho practices, 6 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Cho's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Cho is licensed in Michigan.

CMS data shows 547 Medicare services from Dr. Cho across 17 procedure codes in 2024, for 314 Medicare patients. Medicare paid $67,885 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 314 Medicare patients who saw Dr. Cho in 2024. The largest group is 75 to 84, with 122 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 18% are also on Medicaid. Their average risk score is 1.94, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Cho's median patient age at 77, with 44% women.

In 2024, Dr. Cho wrote 204 Medicare Part D claims for 70 patients. 80% of them were for generic drugs. CMS names the drug for 122 of them, across 6 drugs with 11 or more claims each, at $26,087 in total drug cost. In 2023, CMS named 444 claims across 15 drugs.

Dr. Cho accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 12 procedures of coronary angioplasty and stenting by Dr. Cho, more than 33% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

CMS Open Payments shows 643 general payments to Dr. Cho from 39 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 76% of the total. Edwards Lifesciences Corporation paid the most, $7,997.